Two studies on exenatide 162,166 and one on liraglutide 162 showed no effect of these GLP-1RAs on depression-like behavior
If you have chest pain, dizziness, severe shortness of breath, or new exercise limits, seek medical review before increasing activity
The IV therapy age requirement exists because childrens bodies respond to fluid shifts differently, and the oversight they need goes beyond what most wellness IV providers are equipped to deliver

Metabolism & Elimination Limited characterization of specific metabolic pathways has been published for both peptides: CJC-1295 (NO DAC): Peptidase-mediated degradation represents primary metabolic pathway Four amino acid substitutions provide enhanced resistance to dipeptidyl peptidase-IV Metabolites and degradation products not fully characterized in published literature Clearance from circulation within hours despite sustained pharmacodynamic effects Ipamorelin: Clearance of 0.078 L/h/kg in human pharmacokinetic studies Rapid elimination from plasma following distribution phase Metabolic pathways likely involve proteolytic cleavage at peptide bonds No significant accumulation observed with repeated dosing in animal models A notable pharmacokinetic-pharmacodynamic disconnect exists: despite relatively short plasma half-lives (30 minutes to 2 hours), growth hormone secretory effects persist for 6+ hours, suggesting either active metabolites, tissue retention, or persistent receptor signaling cascade activation

If nausea is severe enough to prevent eating for more than a day, contact your healthcare provider